**Core Concept**
Thrombin receptor antagonists are a class of medications that inhibit the action of thrombin, a key enzyme in the coagulation cascade, by blocking its binding to its receptor, protease-activated receptor-1 (PAR-1). This class of drugs is used to prevent thrombotic events, such as myocardial infarction and stroke.

**Why the Correct Answer is Right**
Thrombin receptor antagonists work by blocking the activation of protease-activated receptor-1 (PAR-1) on platelets and endothelial cells, which in turn prevents the recruitment of additional platelets and the formation of a blood clot. By inhibiting thrombin's action, these drugs reduce the risk of thrombotic events. Examples of thrombin receptor antagonists include dabigatran, which is a direct thrombin inhibitor, but the correct answer is a thrombin receptor antagonist.

**Why Each Wrong Option is Incorrect**
**Option A:** Dabigatran is a direct thrombin inhibitor, not a thrombin receptor antagonist.
**Option B:** Apixaban is a factor Xa inhibitor, not a thrombin receptor antagonist.
**Option C:** Rivaroxaban is also a factor Xa inhibitor, not a thrombin receptor antagonist.
**Option D:** Edoxaban is a factor Xa inhibitor, not a thrombin receptor antagonist.

**Clinical Pearl / High-Yield Fact**
Thrombin receptor antagonists are distinct from direct thrombin inhibitors, which directly inhibit the activity of thrombin. The correct answer is the only one that specifically targets the thrombin receptor, making it a unique class of anticoagulant medications.

**Correct Answer: C. Melagatran**